Form 144: Proposed sale of 5,957 common shares

Filer submitted a Form 144 reporting the proposed sale of 5,957 common shares.

Rhea-AI Filing Summary

Filer submitted a Form 144 reporting the proposed sale of 5,957 common shares. The filing lists proposed sales dated 03/13/2026 tied to options granted on 04/29/2021 (4,479 shares) and 05/20/2022 (1,478 shares), with proceeds described as cash.

The notice names Fidelity Brokerage Services LLC as the broker for the transactions and lists NASDAQ as the exchange. The filing records proposed sale activity under Regulation 144 procedures on 03/13/2026.

Insights

Securities Counsel

Regulation 144 notice for proposed resale of 5,957 common shares.

The filing documents proposed dispositions of common shares totaling 5,957, dated 03/13/2026, including option-related lots of 4,479 and 1,478 shares from grants on 04/29/2021 and 05/20/2022.

Cash sale is the indicated method and Fidelity Brokerage Services LLC is listed as broker. Timing and any eligibility conditions under Rule 144 are not detailed in the excerpt; subsequent filings or broker confirmations would specify execution and settlement details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does LIF's Form 144 report?

The filing reports a proposed sale of 5,957 common shares on 03/13/2026. It lists two option-related tranches of 4,479 and 1,478 shares tied to option grants dated 04/29/2021 and 05/20/2022.

Who is listed as the broker on the LIF Form 144?

Fidelity Brokerage Services LLC is named as the broker, with address details shown. The filing indicates the transactions relate to common shares to be sold on or about 03/13/2026 under the broker's handling.

How many shares come from option grants in the filing?

The filing shows option-related amounts of 4,479 shares (option grant 04/29/2021) and 1,478 shares (option grant 05/20/2022), which together correspond to the reported total of 5,957 shares.

What sale method is indicated in LIF's filing?

The excerpt labels the proceeds treatment as cash, indicating cash disposition of shares. It does not provide execution timing or settlement details beyond the transaction date of 03/13/2026, so confirmation will appear in trade records or later filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 01:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001932666
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Life360, Inc.
SEC File Number	001-42120
Address of Issuer	1900 SOUTH NORFOLK STREET, SUITE 310 SAN MATEO CALIFORNIA 94403
Phone	415-484-5244
Name of Person for Whose Account the Securities are To Be Sold	Wiadrowski David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5957	246235.70	80198613	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/13/2026	Option Granted - 04/29/2021	Issuer			4479	03/13/2026	Cash
Common	03/13/2026	Option Granted - 05/20/2022	Issuer			1478	03/13/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Louis Kurnick, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Stoddart Wiadrowski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)